Background: The treatment of advanced heart failure in children and infants poses a serious management problem. Heart failure in that patient group is usually of congenital etiology. The treatment schedules for pediatric patients are in most cases adapted from the guidelines for treatment of adults. Up to 2009, the treatment of that extremely difficult group of patients was limited to pharmacological therapy and occasional heart transplantations. Constantly increasing problems with recruiting donors, especially for the pediatric group, contribute to the fact that mechanical support with the use of ventricular assist devices is for many children the only chance to survive the period of waiting for a heart donor. Aim: The aim of the study was to analyze the results of treatment of circulatory support in Poland and assessment of the advisability of this method for treatment of children with severe heart failure. Methods: This method of treatment of pediatric patients is currently used in three Polish centers. From December 28th, 2009 to August 1st, 2015, 27 implantations of Berlin Heart EXCOR mechanical circulatory support system were performed in children aged from 1 month to 16 years (10 patients below 1 year of age; 37%). Left ventricular assist devices were implanted to 21 patients, whereas the remaining children received biventricular support. The most common reason for using this method was heart failure developed in the course of cardiomyopathy. In one case, heart failure after Fontan operation was the indication. Results: The duration of the circulatory support period ranged from 6 to 1215 days. It was followed by successful heart transplantations in 10 patients (37%), in 5 (18.1%) it resulted in regeneration of the heart, enabling explantation of the device, whereas three children are still waiting for transplantations. Nine children (33%) died during the therapy because of thromboembolic complications. Conclusions: As it follows from our data, circulatory support utilizing the Berlin Heart system is an effective and promising method used as a bridge to cardiac transplantation, or regeneration of the myocardium in pediatric patients. In the group of the youngest and the most difficult patients, the method requires close cooperation of the medical and nursing personnel. Background: The treatment of advanced heart failure in children and infants poses a serious management problem. Heart failure in that patient group is usually of congenital etiology. The treatment schedules for pediatric patients are in most cases adapted from the guidelines for treatment of adults. Up to 2009, the treatment of that extremely difficult group of patients was limited to pharmacological therapy and occasional heart transplantations. Constantly increasing problems with recruiting donors, especially for the pediatric group, contribute to the fact that mechanical support with the use of ventricular assist devices is for many children the only chance to survive the period of waiting for a heart donor. Aim: The aim of the study was to analyze the results of treatment of circulatory support in Poland and assessment of the advisability of this method for treatment of children with severe heart failure. Methods: This method of treatment of pediatric patients is currently used in three Polish centers. From December 28th, 2009 to August 1st, 2015, 27 implantations of Berlin Heart EXCOR mechanical circulatory support system were performed in children aged from 1 month to 16 years (10 patients below 1 year of age; 37%). Left ventricular assist devices were implanted to 21 patients, whereas the remaining children received biventricular support. The most common reason for using this method was heart failure developed in the course of cardiomyopathy. In one case, heart failure after Fontan operation was the indication. Results: The duration of the circulatory support period ranged from 6 to 1215 days. It was followed by successful heart transplantations in 10 patients (37%), in 5 (18.1%) it resulted in regeneration of the heart, enabling explantation of the device, whereas three children are still waiting for transplantations. Nine children (33%) died during the therapy because of thromboembolic complications. Conclusions: As it follows from our data, circulatory support utilizing the Berlin Heart system is an effective and promising method used as a bridge to cardiac transplantation, or regeneration of the myocardium in pediatric patients. In the group of the youngest and the most difficult patients, the method requires close cooperation of the medical and nursing personnel.